DNTH vs MKC · rev $6.2M vs P/E 8.4, $13.56B cap
Dianthus Therapeutics Inc. (DNTH) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
MKC does not have a complete income-statement cache yet.
DNTH currently screens at market cap $4.40B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the DNTH and MKC stock pages for the full models.
Not investment advice.